encyclopedia jump navigation jump search prostate_cancer name prostate diagram position prostate rectum position prostate oncology symptom difficulty blood urine pain pelvis back onset age risk factor age family history race method tissue biopsy image diagnosis hyperplasia treatment surveillance surgery radiation therapy hormone therapy chemotherapy survival rate frequency case death 
prostate_cancer development cancer prostate gland system prostate_cancer cancer cell prostate area body bone lymph node symptom stage difficulty blood urine pain pelvis back disease hyperplasia symptom symptom feel due level blood cell 
factor risk prostate_cancer age family history disease race case male age relative disease risk united states population population factor diet meat meat milk product vegetable association gonorrhea reason relationship risk mutation prostate_cancer biopsy image cancer part body 
prostate_cancer screen antigen psa test cancer detection outcome decision make screen year test life expectancy 
inhibitor cancer risk cancer risk prevention vitamin mineral risk 
case surveillance wait treatment combination surgery radiation therapy hormone therapy chemotherapy prostate disease bone pain medication therapy outcome person age health problem cancer men prostate_cancer disease survival rate united states second type cancer cause death men  men death cancer male country world rate world detection area psa test study male cause prostate_cancer age content 
sign symptom risk factor genetics exposure infection diagnosis image biopsy tumor marker prevention diet lifestyle screen management surveillance cancer care classification system life expectancy epidemiology united states canada europe history society culture research cancer model diagnosis reference link 
sign symptom diagram prostate_cancer urethra symptom 
prostate_cancer symptom 
prostate_cancer symptom disease hyperplasia 
urination urination night difficulty start stream urine blood urine urination 
study patient care evaluation patient prostate_cancer symptom symptom 
prostate_cancer dysfunction prostate gland urethra 
change gland function 
va deposit fluid urethra secretion prostate gland semen content prostate_cancer problem function performance difficulty erection ejaculation 
prostate_cancer part body symptom 
symptom bone pain vertebrae bone spine pelvis rib 
spread cancer bone femur part bone 
prostate_cancer spine cord leg weakness incontinence risk factor 
understand cause prostate_cancer risk factor obesity age family history 
prostate_cancer men age 
age time diagnosis men prostate_cancer 
study men cause prostate_cancer men men 
men family member prostate_cancer risk disease men prostate_cancer family risk men brother men father 
united states case prostate_cancer death prostate_cancer men blood pressure prostate_cancer risk prostate_cancer lack exercise genetics 
background prostate_cancer risk association race family gene variant 
men father brother prostate_cancer risk prostate_cancer relative risk men family history united states prostate_cancer men men men contrast incidence mortality rate men white 
study twin scandinavia prostate_cancer risk factor 
gene prostate_cancer gene 
mutation brca1 risk factor cancer breast_cancer women prostate_cancer gene hereditary prostate_cancer gene receptor vitamin  receptor gene family fusion cancer cell growth fusion rearrangement chain 
association study polymorphism prostate_cancer study risk prostate_cancer 
example individual allele pair snp rs10993994 time risk prostate_cancer cc allele pair 
snp part prostate_cancer risk men men descent  allele snp promoter region gene amount protein cell prostate 
obesity blood level testosterone risk prostate_cancer 
fruit vegetable benefit prostate_cancer evidence role fruit vegetable prostate_cancer occurrence meat meat effect study meat consumption risk study 
lower blood level vitamin risk prostate_cancer 
acid supplement effect risk prostate_cancer exposure 
link prostate_cancer medication procedure condition use medication statin prostate_cancer risk infection 
infection inflammation prostate prostatitis chance prostate_cancer study infection prostate_cancer blood flow area 
infection infection chlamydia syphilis risk 
virus study role prostate_cancer evidence review  risk risk 
research war veteran agent orange risk prostate_cancer recurrence surgery 
evidence cohort study ejaculation prostate_cancer risk result trial benefit association vasectomy prostate_cancer research relationship 
prostate part system make store fluid 
adult men prostate gram pelvis bladder front rectum 
prostate part urethra tube urine bladder urination semen ejaculation location prostate disease urination ejaculation defecation 
prostate gland fluid semen 
prostate_cancer cell prostate gland cancer cell 
prostate gland hormone androgen work 
testosterone teste gland dihydrotestosterone testosterone prostate 
sex characteristics hair muscle mass 
prostate_cancer lymph node prostate_cancer bone 
prostate_cancer adenocarcinoma cancer semen-secret prostate gland cell cancer cell 
region prostate gland adenocarcinoma zone 
clump cancer cell prostate gland condition carcinoma situ neoplasia pin 
proof pin cancer precursor cancer 
time cancer cell prostate tissue stroma tumor 
tumor organ vesicle rectum tumor cell ability bloodstream system 
prostate_cancer tumor mass cell area body 
invasion organ metastasis 
prostate_cancer bone lymph node rectum bladder ureter progression 
route metastasis bone plexus prostate vein 
prostate zinc-accumulate organ 
protein zip1 transport zinc prostate cell 
role metabolism cell order citrate component semen 
process zinc accumulation alteration metabolism citrate production energy prostate cell amount energy atp order task 
prostate_cancer cell zinc 
prostate_cancer cell energy citrate abundance energy 
absence zinc silence gene transporter protein 
tumor suppressor gene product gene 
cause silence 
strategy transport zinc prostate cell cell animal 
pathway apoptosis cell 
ingestion zinc concentration zinc prostate cell transporter 
loss cancer suppressor gene carcinogenesis chromosome 8p 13q 16q 
mutation prostate_cancer set mutation event pathology prostate_cancer 
tumor suppressor gene role prostate_cancer gene kai1 
percent men prostate_cancer copy gene time diagnosis frequency loss e-cadherin cd44 
transcription factor cancer cell apoptosis development prostate_cancer 
pi3kakt cascade growth factor cascade prostate_cancer cell survival protection apoptosis inhibitor apoptosis xiap prostate_cancer cell survival growth target research inhibitor apoptosis cascade function cancer cell proliferation cytokine-1 adhesion kinase pathway prostate_cancer cell growth survival 
receptor prostate_cancer cell target cancer research study receptor mouse study membrane antigen development prostate_cancer folate level cancer cell use increase folate use glutamate diagnosis prostate_cancer ct scan 
cancer position detection psa test research benefit test harm test treatment 
cancer society men learn risk benefit test treatment 
age brother father condition age talk doctor pro con test test choice 
test information prostate tract 
examination doctor prostate abnormality 
tract bladder camera tube urethra 
ultrasonography picture prostate sound wave probe rectum 
test diagnosis prostate_cancer biopsy removal piece prostate examination 
ultrasound resonance image mry image method prostate_cancer detection 
use ultrasound prostate biopsy area tissue structure ultrasound wave 
ultrasound tissue resolution 
prostate mri tissue resolution ultrasound 
mry risk people surveillance risk stage disease risk bone disease 
mry target prostate biopsy fusion mry ultrasound 
men candidate surveillance fusion prostate biopsy cancer ultrasound biopsy 
prostate mri plan men prostatectomy 
surgeon bundle return continence help difficulty 
prostate mri report system 
acronym imaging-report data system standard service resonance image image creation report 
biopsy article biopsy needle biopsy prostate_cancer adenocarcinoma invasion 
cancer biopsy 
biopsy urologist radiologist tissue sample prostate rectum 
biopsy gun insert hollow-core needle side prostate second 
biopsy outpatient basis hospitalization 
antibiotics complication fever tract infection sepsis course dose antibiotic percent men report discomfort prostate biopsy score article score 
tissue sample microscope cancer cell feature score cancer 
membrane antigen transmembrane folate hydrolase activity protein prostate_cancer tissue gleason score marker 
tissue sample presence psa tumor marker order origin cell 
cell carcinoma type prostate_cancer psa researcher way screen type prostate_cancer part body 
bcl-2 development prostate_cancer due level expression tumour stage pathology 
upregulation bcl-2 ablation prostate carcinoma cell line rat model connection expression prostate_cancer progression 
expression ki-67 immunohistochemistry predictor patient outcome men prostate_cancer article prostate_cancer stage diagram stage prostate_cancer 
part prostate_cancer stage cancer 
stage help prognosis therapy 
system four-stage system 
component size tumor number lymph node presence metastase 
distinction stage system cancer prostate 
system cancer prostate_cancer 
test evidence spread 
specialty organization use pet scan ct scan bone scan physician stage prostate_cancer risk metastasis test case ct scan spread pelvis bone scan look spread bone coil resonance image capsule vesicle 
bone scan appearance bone density area bone cancer 
prostate biopsy pathologist sample microscope 
cancer pathologist grade tumor 
grade tumor tissue prostate tissue tumor 
system grade prostate score abnormality 
pathologist number pattern microscope pattern 
sum number score 
stage method 
sclerosis bone spine prostate_cancer metastase ct image 
sclerosis bone spine prostate_cancer metastase ct image 
sclerosis bone pelvis prostate_cancer metastase 
prevention diet lifestyle 
data relationship diet prostate_cancer light rate prostate_cancer consumption diet evidence association tran fat carbohydrate intake risk prostate_cancer evidence role acid prostate_cancer risk prostate_cancer research vitamin supplement effect risk calcium intake prostate_cancer 
fish death occurrence evidence rate prostate_cancer diet evidence food lycopene selenium vegetable bean legume risk prostate_cancer cancer 
men exercise risk activity risk prostate_cancer 
inhibitor risk prostate_cancer data effect risk death chance case article prostate_cancer screen 
prostate_cancer screen effort cancer symptom 
option exam antigen psa blood test screen disruption consequence harm screen detection cancer benefit decision-make approach option screen consultation physician positive negative 
united states service task force decision psa screen decision patient physician men year age psa screen male age center disease control prevention conclusion society oncology college physician screen year life expectancy decision person question risk benefit general benefit psa test prostate_cancer screen harm screen treatment 
urological association guideline benefit prostate_cancer mortality man men period harm test treatment 
aua offer screen decision make screen year kingdom program screen prostate_cancer management article management prostate_cancer 
decision prostate_cancer treatment 
prostate_cancer form men treatment treatment person health problem symptom 
approache treatment surveillance prostate_cancer management management approache intent surveillance intent 
option stage disease score psa level 
factor age health person view treatment side effect 
treatment side effect dysfunction incontinence treatment discussion goal therapy risk lifestyle alteration 
combination treatment option prostate_cancer 
guideline treatment situation estimation person life expectancy people questionnaire knowledge understand treatment option 
treatment choice question radiotherapy surgery result outcome respect bowel function year 
radiation therapy prostatectomy option surgery quality life hand radiation therapy failure complication increase bladder colon cancer 
disease prostatectomy wait 
meta-analysis effect position urination male prostate enlargement sit 
empty trend flow time surveillance 
men prostate_cancer surveillance 
observation tumor time intention treatment sign cancer progression 
surveillance wait term treatment program monitor assumption palliative treatment disease 
surveillance tumor sign growth appearance symptom 
monitor process psa test examination prostate biopsy 
goal surveillance side effect treatment tumor people problem 
approach cancer anxiety people cancer cancer 
people prostate_cancer harm person cause cancer 
treatment prostate_cancer treatment prostate_cancer surgery prostatectomy radiation therapy prostate beam radiation therapy particle therapy ultrasound chemotherapy chemotherapeutic drug therapy combination 
use antigen psa screen diagnosis age cancer stage majority case men year case men year cancer network guideline life expectancy year treatment decision practice patient treatment option radiation therapy therapy wait pattern factor patient preference regard quality life addition prostate_cancer risk factor pretreatment psa gleason score stage 
life expectancy advance treatment disease patient consequence prostate_cancer 
interest role prostate_cancer treatment modality surgery radiation population disease 
cancer prostate treatment option doctor prostate_cancer use variety nomogram probability spread 
treatment surveillance beam radiation therapy hifu surgery general men cancer prostate 
therapy chemotherapy disease prostate 
exception therapy radiation treatment tumor amount metastase therapy stage 
process tumor therapy chemotherapy treatment cancer 
cancer vaccine result benefit increase survival men prostate_cancer 
hormone cancer treatment year resume growth hormone therapy 
prostate_cancer androgen-independent prostate_cancer term castration-resistant hormone castration treatment reduction androgentestosteronedht chemical mean cancer reliance hormone receptor activation 
cancer docetaxel treatment crpc survival benefit month chemotherapy treatment combination thalidomide prednisone treatment 
treatment sipuleucel-t increase survival month second line therapy increase survival month placebo enzalutamide second line agent survival advantage placebo 
trial crpc chemotherapy 
subset people drug cell characteristics stem cell desire outcome people crpc claim dose combination therapy androgen agent combination cell 
advance combination block agent cell differentiation therapy drug care 
treatment prostate_cancer treatment prostate_cancer surgery prostatectomy radiation therapy prostate beam radiation therapy ultrasound chemotherapy chemotherapeutic drug therapy combination 
prostate_cancer rate country rest world 
risk factor prostate_cancer country life expectancy diet meat 
access screen program detection rate 
united states prostate_cancer time diagnosis survival rate metastase survival rate japan death prostate_cancer rate united states europe india half people prostate_cancer prostate year men time prostate_cancer prostate_cancer death men shanghai china nigeria men prostate_cancer year men disease survival month 
patient treatment indicator disease outcome stage psa level score 
general grade stage prognosis 
risk patient 
prediction experience group patient cancer stage 
charles huggins ablation therapy regression androgen-dependent prostate_cancer nobel prize physiology medicine discovery 
ablation therapy remission  patient therapy median survival month 
remission phenotype survival month time initiation ablation therapy prostate_cancer progression possibility way cancer change lack androgen patient 
classification system prostate adenocarcinoma type type prostate_cancer 
needle biopsy 
prostate_cancer men result disease 
decision treatment type time estimation risk tumor treatment progress metastase mortality 
tool outcome stage recurrence surgery radiation therapy 
combine stage grade psa level number percentage biopsy core age information 
classification men risk stage grade psa 
practice research set 
downside system parameter gleason score psa patient 
table outcome margin status extension vesicle invasion variable table 
kattan recurrence surgery radiation therapy data time diagnosis surgery 
nomogram paper graph software website computer 
score likelihood disease time interval treatment 
cancer risk assessment score status recurrence surgery 
accuracy nomogram paper table calculator 
point psa grade stage age percentage core sum score point double risk recurrence 
score data database 
patient patient capsure search registry data veteran administration center cohort germany cohort johns hopkins university metastasis mortality radiation therapy wait deprivation therapy 
life expectancy 
life expectancy projection average population lifestyle factor number 
example study man year life bmy year life bmy men weight 
smoker year smoker year 
time evidence surgery beam radiation advantage regard death rate surgery surgery men form cancer 
information seed radiation life treatment data 
people disease prostate_cancer year diagnosis 
men age disease survival year death cause 
men disease prostate_cancer mortality year diagnosis age diagnosis nature prostate_cancer epidemiology death prostate_cancer inhabitant data   
prostate_cancer second cancer cancer cause cancer death male prostate_cancer death death rate prostate_cancer world 
rate country south east asia europe north america australia new zealand prostate_cancer men men figure men 
incidence rate prostate_cancer men united states time counterpart shanghai tianjin rate rate detection prostate_cancer incidence china japan rate country 
men prostate_cancer age majority case cancer concern 
men prostate_cancer identification condition treatment men effect possibility live united states new case death prostate_cancer united states male 
case  prostate_cancer death united states 
prostate_cancer cause cancer death men lung_cancer cancer 
cancer cancer-relate death 
incidence rate increase inception use antigen psa screen fall incidence 
decline prostate_cancer incidence rate men year  
 mortality rate 
decline mortality rate jurisdiction benefit psa screen observation phenomena treatment 
lifetime risk prostate_cancer diagnosis lifetime risk disease 
cancer statistics cancer society cancer institute proportion disease stage white american proportion disease stage white american 
autopsy study men increase occult prostate_cancer age men year 
cancer men cancer men score score indicator prostate_cancer canada 
prostate_cancer type cancer men 
 men prostate_cancer europe 
europe cancer breast case 
kingdom second cause cancer death lung_cancer case year die history 
prostate anatomist massa anatomist andreas vesalius prostate_cancer prostate_cancer disease life expectancy detection method century 
treatment prostate_cancer surgery obstruction removal gland prostatectomy hugh  
young johns hopkins hospital removal teste prostate_cancer success 
resection prostate prostatectomy relief obstruction middle century function 
retropubic patrick walsh approach removal prostate lymph node maintenance function 
charles  
huggins study testosterone production men prostate_cancer 
discovery castration huggins nobel prize physiology medicine role hormone reproduction andrzej  
roger nobel prize physiology medicine work 
receptor agonist prostate_cancer 
radiation therapy prostate_cancer century radium implant 
beam radiotherapy x-ray radiation source middle century 
seed prostate_cancer 
chemotherapy prostate_cancer 
regimen cyclophosphamide 5-fluorouracil regimen host chemotherapy drug society culture 
people prostate_cancer encounter disparity awareness fund media coverage treatment outcomescompare cancer prevalence guardian britain nurse breast_cancer prostate_cancer 
wait time referral diagnosis week breast_cancer month prostate_cancer report 
prostate_cancer coalition prostate_cancer drug market treat breast_cancer 
time bia cancer fund discrepancy kingdom government cancer charity cancer research uk equality campaigner author warren farrell spend inequality example government women health men health 
area detection government fund mandate prostate_cancer screen breast_cancer program 
example report state mandate insurance coverage routine breast_cancer screen prostate_cancer prostate_cancer experience media coverage cancer study coalition breast_cancer story cover cancer prostate 
prostate_cancer awareness month place september number country 
ribbon cause research journal prostate_cancer journal 
phase trial chemo-naive patient population fda approval  enzalutamide treatment prostate_cancer 
phase trial patient bone metastasis 
analysis survival quality life 
study reason placebo group treatment 
bone isotope cancer cell alpha source 
food drug administration fda schedule priority review program approval medicine agency 
inhibitor olaparib promise trial trial crpc checkpoint inhibitor inhibitor tok-001 immunotherapy 
medication block target ligand bind domain 
decade molecule domain therapy advantage prostate_cancer therapy pre-clinical 
5-lipoxygenase role survival prostate_cancer cell target enzyme therapy tumor growth cancer metastasis cell death cancer cell arachidonate inhibitor cell death prostate_cancer cell 
prostate_cancer progression profile prostate_cancer study link signature prostate_cancer cancer model 
scientist prostate_cancer cell line mechanism progression prostate_cancer 
pc-3 du145 prostate_cancer cell line 
cancer cell line lymph node lesion adenocarcinoma 
cell adenocarcinoma bone brain 
cell receptor cell 
transcription factor receptor family 
development prostate signal development prostate_cancer 
proliferation cell proliferation pc-3 du-145 cell 
elevation expression prostate patient androgen-independent atcc cell deprivation study prostate_cancer progression 
lncap cell expression prostate antigen treatment 
paradox proliferation androgen-independent prostate_cancer cell 
virus prostate report virus find contamination journal science article diagnosis 
present area research investigation method prostate tumor detection 
test presence mrna fluid prostate urine sample investigation 
mrna prostate cell prostate_cancer cell 
test result specimen ratio mrna psa mrna 
replacement serum psa level test tool men prostate_cancer biopsy serum psa biopsyrebiopsy 
expression pca3 sample likelihood biopsy presence cancer cell prostate 
prostate_cancer foundation cancer 
